Table 2.
Variation of the clinical parameters per group and per assessment moment.
| Control group (n = 30) | Intervention group (n = 30) | |||||
|---|---|---|---|---|---|---|
| Baseline | 30 days | P | Baseline | 30 days | P | |
| BMI, Kg/m2 | 23.55 ± 3.51 | 23.63 ± 3.49 | 0.22 | 22.18 ± 3.87 | 22.15 ± 3.92 | 0.61 |
| HR, bpm | 75.00 ± 15.19 | 74.15 ± 19.07 | 0.90 | 72.20 ± 10.30 | 72.20 ± 9.78 | 1.00 |
| bSBP, mmHg | 120.00 ± 12.56 | 121.57 ± 12.00 | 0.62 | 120.33 ± 7.67 | 116.67 ± 7.48 | 0.10 |
| bDBP, mmHg | 68.21 ± 7.50 | 68.07 ± 6.84 | 0.92 | 67.67 ± 6.78 | 66.00 ± 6.60 | 0.42 |
| cSBP, mmHg | 109.92 ± 13.66 | 111.46 ± 12.25 | 0.90 | 110.6 ± 8.49 | 109.00 ± 8.37 | 0.53 |
| cPP, mmHg | 43.00 ± 10.95 | 43.00 ± 9.99 | 1.00 | 44.92 ± 10.52 | 42.33 ± 10.18 | 0.19 |
| AiX, % | −17.54 ± 13.78 | −16.15 ± 15.72 | 0.68 | −15.88 ± 10.75 | −22.57 ± 11.16 | 0.07 |
| ASI, | 0.15 ± 0.02 | 0.14 ± 0.07 | 0.10 | 0.16 ± 0.01 | 0.13 ± 0.01 | 0.00 |
| PWV, m/s | 6.28 ± 0.95 | 6.30 ± 1.13 | 0.52 | 6.13 ± 0.41 | 5.83 ± 0.53 | 0.02 |
| FMD, % | 12.85 ± 4.51 | 13.23 ± 5.76% | 0.70 | 13.91 ± 4.71% | 23.22 ± 7.64% | 0.00 |
AiX: augmentation index; ASI: distensibility index; BMI: body mass index; bDBP: brachial diastolic blood pressure; bSBP: brachial systolic blood pressure; cPP: central pulse pressure; cSBP: central systolic blood pressure; HR: heart rate; PWV: pulse wave velocity; FMD: flow-mediated dilation.